Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Immunity”

486 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 486 results

Testing effectiveness (Phase 2)Looking for participantsNCT06909110
What this trial is testing

Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity

Who this might be right for
AdenovirusCytomegalovirus InfectionsEpstein-Barr Virus Infections
Jessie L. Alexander 25
Testing effectiveness (Phase 2)Study completedNCT02307227
What this trial is testing

Phase II Study With Trastuzumab + Paclitaxel in Locally Advanced HER2+ Tumors or Epirubicin + Taxotere in HER2- Tumors

Who this might be right for
Breast Neoplasms
Centro di Riferimento Oncologico - Aviano 46
Post-approval studies (Phase 4)Study completedNCT00090038
What this trial is testing

Effect of Rituximab on Immunological Recall Response to Specific Antigens in the Treatment of Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Biogen 168
Post-approval studies (Phase 4)Ended earlyNCT05075538
What this trial is testing

COVID-19: Immune Response in Patients With Cancer Undergoing mRNA Vaccination Against SARS-CoV-2

Who this might be right for
Cancer
Jules Bordet Institute 152
Not applicableStudy completedNCT02846103
What this trial is testing

Study of Anti-telomerase T CD4 Immunity in Metastatic Lung Cancer

Who this might be right for
Lung Cancer
Centre Hospitalier Universitaire de Besancon 321
Testing effectiveness (Phase 2)Study completedNCT02474186
What this trial is testing

Phase II Study for Solid Metastatic Tumors

Who this might be right for
Breast CancerMetastatic Breast CancerSolid Tumor
NYU Langone Health 41
Not applicableStudy completedNCT00001603
What this trial is testing

The Effects of Upper Airway and Digestive Tract Tumors on the Immune System

Who this might be right for
Esophageal NeoplasmHead and Neck NeoplasmLaryngeal Neoplasm+2 more
National Institute on Deafness and Other Communication Disorders (NIDCD) 93
Testing effectiveness (Phase 2)UnknownNCT02007811
What this trial is testing

Open-label Clinical Trial to Investigate the Safety and Tolerability of Allogeneic B-cell Concentrates for Immune Reconstitution After Allogeneic Stem Cell Transplantation Measured as Response to a Antedated Single Vaccination

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myeloid Leukemia+5 more
University of Erlangen-Nürnberg Medical School 15
Not applicableStudy completedNCT05484687
What this trial is testing

Effect of Intravenous Infusion of Lidocaine on Patients Undergoing Radical Resection of Colorectal Tumors

Who this might be right for
Colorectal TumorsLidocaine
Affiliated Hospital of Nantong University 100
Not applicableUnknownNCT00728871
What this trial is testing

The Correlations Between HPV L1-Specific Immunologic Responses in Cervical Cancer and Cervical Intraepithelial Neoplasia (CIN) Patients and Their Prognosis

Who this might be right for
Cervical CancerCervical Intraepithelial Neoplasia
National Taiwan University Hospital 600
Not applicableUnknownNCT00368615
What this trial is testing

Characterization of the Melanoma-Specific Immune Response

Who this might be right for
Melanoma
University of California, Davis 20
Testing effectiveness (Phase 2)Study completedNCT00004197
What this trial is testing

Vaccine Therapy Plus Sargramostim Following Chemotherapy in Previously Untreated Aggressive Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
University of Nebraska
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06047015
What this trial is testing

Irreversible Electroporation (NanoKnife ®) and Immunotherapy for the Treatment of Stage IV Colorectal Cancer

Who this might be right for
Liver Metastasis Colon Cancer
University of Saskatchewan 12
Not applicableStudy completedNCT04844489
What this trial is testing

Study of the Humoral Response to SARS-CoV-2 Variants and of the Cellular Response After Vaccination Against COVID-19 in Immunocompromised People

Who this might be right for
Autoimmune or Autoinflammatory DiseasesHIVMultiple Sclerosis+2 more
Assistance Publique - Hôpitaux de Paris 377
Not applicableStudy completedNCT01955343
What this trial is testing

Immune Response in Lung Cancer

Who this might be right for
Lung Cancer
Lithuanian University of Health Sciences 100
Early research (Phase 1)Looking for participantsNCT05371132
What this trial is testing

Study to Evaluate CD8 PET Imaging as a Marker of Immune Response to Stereotactic Body Radiation Therapy (ELIXR)

Who this might be right for
Metastatic Malignant Solid NeoplasmLymphoma
City of Hope Medical Center 10
Not applicableLooking for participantsNCT06539832
What this trial is testing

Intestinal Flora and Immunity in Monoclonal Gammopathy Patients

Who this might be right for
Multiple MyelomaMGUSGut Microbiota+2 more
Zhujiang Hospital 300
Not applicableStudy completedNCT00001158
What this trial is testing

Studies of the Immune Response in Normal Subjects and Patients With Disorders of the Immune System

Who this might be right for
Immunologic Deficiency SyndromesNeoplasms
National Cancer Institute (NCI)
Post-approval studies (Phase 4)Study completedNCT00919321
What this trial is testing

The Duration of Humoral Immunity and the Memory Cell Function After Vaccination With 7-valent Pneumococcal Conjugate Vaccine in CLL

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)
Tampere University Hospital 32
Testing effectiveness (Phase 2)Ended earlyNCT04166383
What this trial is testing

VB-111 in Combination With Nivolumab in People With Metastatic Colorectal Cancer (mCRC)

Who this might be right for
Metastatic Colorectal CancerColorectal NeoplasmsColorectal Carcinoma+2 more
National Cancer Institute (NCI) 14
Load More Results